Paydirt
Insider filing · BCAX

David Raben sold $406K of Bicara Therapeutics (BCAX)

Executed Oct 9 2025, disclosed Oct 10 2025, 1 day later.

Value, as filed
$406K
22,000 sh × $18.45
Executed
Oct 9 2025
the trade date, as filed
Disclosed
Oct 10 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
DR David Raben Chief Medical Officer profile →

David Raben (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $302K of BCAX (16,300 sh × $18.52, as filed), executed Mar 4.

The name
BCAX Bicara Therapeutics Inc. BCAX · Healthcare · 40 filings in 24 months ticker →

Healthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by David Raben in BCAX
BCAXSALE Bicara Therapeutics Inc. $126K
5,500 sh × $22.88
Exec Apr 27
Filed Apr 28 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $104K
5,500 sh × $18.95
Exec Mar 25
Filed Mar 26 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $302K
16,300 sh × $18.52
Exec Mar 4
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $101K
5,500 sh × $18.45
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET